Key result
Anticoagulation successfully treats PE 3 weeks after hemorrhagic stroke in a case report.
Why the study?
Recent hemorrhagic stroke is a contraindication to anticoagulation, but some patients develop deep venous thrombosis creating a management dilemma.
Does conventional anticoagulant treatment improve outcomes in a patient with pulmonary embolism 3 weeks after hemorrhagic stroke?
Case Report (n=1)
Does conventional anticoagulant treatment improve outcomes in a patient with pulmonary embolism 3 weeks after hemorrhagic stroke?
Conventional anticoagulant treatment was successfully used in a patient with pulmonary embolism 3 weeks after a hemorrhagic stroke, despite recent stroke being a recognized contraindication.
Case suggests feasible anticoagulation for select PE after recent hemorrhagic stroke; leaves open need for prospective trials before practice change.
Recent stroke is a recognized contraindication to anticoagulation. However, some patients with a recent hemorrhagic stroke develop deep venous thrombosis. This creates a dilemma whereby the physicians have to navigate the best in the risky line of management. We report a 65-year-old man with pulmonary embolism 3 weeks after hemorrhagic stroke. He was given conventional anticoagulant treatment and was discharged with clinical improvement 2 weeks later.
No takes yet. Share an insight, caveat, or question.
Chima et al. (2023) conducted a case report in Pulmonary embolism after hemorrhagic stroke (n=1). Conventional anticoagulant treatment was evaluated on Clinical improvement. Conventional anticoagulant treatment was successfully used in a 65-year-old man with pulmonary embolism 3 weeks after hemorrhagic stroke, leading to clinical improvement and discharge 2 weeks later.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: